MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS
0475.207.552 · rovalta.com · 27/09/2026
ACTIVE
MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS
Financial year 2025 · Closed on 30/06/2025
Net result-118,5 k €-267,8 %over 1 year
Gross margin-49,2 k €-130,8 %over 1 year
Equity2,1 M €-5,4 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBOMEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS is a Private company with limited liability incorporated in 2001. Its main activity is: Rental and operating of own or leased real estate. Its registered office is in Aalter.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0475.207.552
- Incorporation
- 05/07/2001
- Legal form
- Private company with limited liability
- Registered office
- Urselseweg 182
9910 Aalter · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
- Average workforce
- 0,0 ETP
Activities (NACE)
Joint committees (3)
- 100
- 200
- 218
Signals
Solid equityLow riskGood liquidity
Financials
Source · NBB, 20 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -49,2 k € | -131% | 159,8 k € | +19.6% | 133,6 k € | -19.3% | 165,6 k € | -86.1% | 1,2 M € |
| EBITDA | -56,3 k € | -137% | 152,7 k € | +20.2% | 127,1 k € | -20.1% | 159,1 k € | -76.7% | 683,7 k € |
| Operating result | -121,2 k € | -242% | 85,1 k € | +66.1% | 51,3 k € | -29.9% | 73,2 k € | -85.5% | 505 k € |
| Net result | -118,5 k € | -268% | 70,6 k € | +93.6% | 36,5 k € | -28.9% | 51,3 k € | -83.0% | 302,3 k € |
| Balance sheet | |||||||||
| Equity | 2,1 M € | -5.4% | 2,2 M € | +3.3% | 2,1 M € | +1.7% | 2,1 M € | -14.0% | 2,4 M € |
| Total assets | 2,5 M € | -5.9% | 2,6 M € | +3.4% | 2,6 M € | -12.2% | 2,9 M € | -23.3% | 3,8 M € |
| Cash | 164,1 k € | -1.2% | 166,1 k € | -73.5% | 627,8 k € | -39.3% | 1 M € | -19.3% | 1,3 M € |
| Debts | 408,7 k € | -8.4% | 446,1 k € | +3.9% | 429,2 k € | -47.6% | 819,7 k € | -38.6% | 1,3 M € |
| Other | |||||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | – | 6,2 ETP | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Rottey Erika | Director | since 05/04/2019 | 000 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
ERIKA ROTTEY | Manager | 000 |
Other companies at this address
Urselseweg 182 9910 Aalter| Company | CBE no. |
|---|---|
CasaPharma● Active | 0847.310.935 |
MPCA Group● Active | 0733.963.861 |
M.P.C.A. International● Active | 0732.779.075 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 05/01/2026 | 16/12/2024 | 18/12/2023 | 16/12/2022 | 12/01/2022 | 17/12/2020 |
| General meeting | 15/12/2025 | 16/12/2024 | 15/12/2023 | 15/12/2022 | 15/12/2021 | 15/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 15/12/2025 | 05/01/2026 | Dutch | |
| Abridged model | 30/06/2024 | 16/12/2024 | 16/12/2024 | Dutch | |
| Abridged model | 30/06/2023 | 15/12/2023 | 18/12/2023 | Dutch | |
| Abridged model | 30/06/2022 | 15/12/2022 | 16/12/2022 | Dutch | |
| Abridged model | 30/06/2021 | 15/12/2021 | 12/01/2022 | Dutch | |
| Abridged model | 30/06/2020 | 15/12/2020 | 17/12/2020 | Dutch | |
| Abridged model | 30/06/2019 | 15/12/2019 | 10/01/2020 | Dutch | |
| Abridged model | 30/06/2018 | 14/12/2018 | 17/01/2019 | Dutch | |
| Abridged model | 30/06/2017 | 15/01/2018 | 06/03/2018 | Dutch | |
| Abridged model | 30/06/2016 | 10/01/2017 | 15/02/2017 | Dutch | |
| Abridged model | 30/06/2015 | 15/12/2015 | 12/02/2016 | Dutch | |
| Abridged model | 30/06/2014 | 14/01/2015 | 16/01/2015 | Dutch | |
| Abridged model | 30/06/2013 | 12/02/2014 | 14/02/2014 | Dutch | |
| Abridged model | 30/06/2012 | 15/12/2012 | 28/02/2013 | Dutch | |
| Abridged model | 30/06/2011 | 15/12/2011 | 24/02/2012 | Dutch | |
| Abridged model | 30/06/2010 | 15/12/2010 | 11/02/2011 | Dutch | |
| Abridged model | 30/06/2009 | 15/12/2009 | 23/12/2009 | Dutch | |
| Abridged model | 30/06/2008 | 15/12/2008 | 21/01/2009 | Dutch | |
| Abridged model | 30/06/2007 | 27/12/2007 | 14/02/2008 | Dutch | |
| Abridged model | 30/06/2006 | 27/12/2006 | 24/01/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Rottey Erika | Director | since 05/04/2019 | 000 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
ERIKA ROTTEY | Manager | 000 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other22/07/2026Voorstel inzake partiële splitsing door oprichting
- Registered office14/12/2020MAATSCHAPPELIJKE ZETEL - WIJZIGING RECHTSVORM
- Other09/04/2019STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN
- Capital / shares12/07/2018KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares10/06/2014KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-118,5 k €↓
- 2024Annual accounts 202470,6 k €↑
- 2023Annual accounts 202336,5 k €↓
- 2022Annual accounts 202251,3 k €↓
- 2019Annual accounts 2019302,3 k €↓
- 2018Annual accounts 2018557,7 k €↑
- 2017Annual accounts 2017545,8 k €↑
- 2016Annual accounts 2016369,3 k €↑
- 2015Annual accounts 2015235,7 k €↑
- 2014Annual accounts 2014203,9 k €↑
- 2013Annual accounts 2013160,5 k €↓
- 2012Annual accounts 2012232,8 k €↓
- 2011Annual accounts 2011271,4 k €↑
- 2010Annual accounts 2010261,4 k €↑
- 2009Annual accounts 2009149,7 k €↓
- 2008Annual accounts 2008208,7 k €↑
- 2007Annual accounts 2007111,1 k €
- 05/07/2001IncorporationPrivate company with limited liability